8-KOther Events

THERMO FISHER SCIENTIFIC INC. 8-K Report (Apr 24, 2003)

Filed April 24, 2003For Securities:TMO

Summary

Thermo Electron Corporation (TMO) filed an 8-K on April 24, 2003, reporting its first-quarter 2003 financial results, which ended on March 29, 2003. The report highlights a 2% increase in total revenue to $500.2 million, compared to $491.3 million in the prior year's first quarter. However, when excluding currency effects and the impact of acquisitions and divestitures, organic revenue saw a 5% decline. Diluted GAAP earnings per share (EPS) were $0.22, down from $0.59 in the previous year, which included significant one-time gains. The company also presented adjusted EPS, which increased to $0.22 from $0.20, and an adjusted operating margin of 10.0%, up from 9.5% year-over-year, reflecting a focus on productivity improvements amid challenging economic conditions. The report indicates that the company is navigating a difficult economic climate, with organic revenue declines in key segments like Measurement and Control (down 7%) and Optical Technologies (down 18%). The Life and Laboratory Sciences sector showed flat organic revenue. Despite these top-line pressures, management emphasized productivity gains and strategic investments in product development, including the launch of nearly 30 new products at Pittcon. The company provided full-year 2003 guidance for adjusted EPS between $1.07 and $1.12, underscoring its focus on delivering earnings growth through operational efficiency and innovation.

Key Highlights

  • 1Reported Q1 2003 revenue of $500.2 million, a 2% increase year-over-year.
  • 2Reported Q1 2003 GAAP diluted EPS of $0.22, a decrease from $0.59 in Q1 2002, which included significant one-time gains.
  • 3Reported Q1 2003 adjusted EPS of $0.22, an increase from $0.20 in Q1 2002.
  • 4Organic revenues declined 5% in Q1 2003, excluding currency, acquisitions, and divestitures, indicating market challenges.
  • 5Adjusted operating margin improved to 10.0% in Q1 2003 from 9.5% in Q1 2002, driven by productivity efforts.
  • 6Life and Laboratory Sciences sector saw flat organic revenue; Measurement and Control declined 7%; Optical Technologies declined 18%.
  • 7Launched nearly 30 new products at Pittcon, highlighting investment in product development.
  • 8Provided full-year 2003 adjusted EPS guidance of $1.07 to $1.12.

Frequently Asked Questions

Thermo Fisher Scientific reported first-quarter 2003 revenues of $500.2 million, a 2% increase from the prior year. Diluted GAAP EPS was $0.22, down from $0.59 in Q1 2002 due to one-time gains in the prior year. However, adjusted EPS increased to $0.22 from $0.20, and the adjusted operating margin improved to 10.0%.

The company experienced a 5% decline in organic revenue in the first quarter of 2003, excluding currency effects and M&A. The Life and Laboratory Sciences segment was flat organically, while Measurement and Control declined 7% and Optical Technologies fell 18%, reflecting challenging economic conditions in their respective markets.

Management highlighted strong productivity improvements as a key driver of improved margins despite top-line pressures. The company is also heavily investing in product development, evidenced by the launch of nearly 30 new products at Pittcon. They are positioning themselves for faster EPS growth when end markets recover.

The company projects adjusted EPS for the full year 2003 to be in the range of $1.07 to $1.12. This guidance excludes certain items, such as amortization of acquisition-related intangible assets, which are difficult to predict.